KING STREET CAPITAL MANAGEMENT, L.P.
Institutional investor · Portfolio as of Q4 2022
Top Holdings17 positions
Stock | Shares | Value | Weight | Avg Buy | Est. P&L | Held | Conviction |
|---|---|---|---|---|---|---|---|
VANGUARD S/T CORP BOND ETF | 4.5M | $341M | 59.0% | $66.20 | +0.86% | 2 qtrssince 2022-Q3 | Increased 100 |
| 101M | $74.4M | 12.9% | — | — | — | Increased 66 | |
| 120.5M | $66.9M | 11.6% | — | — | — | New 94 | |
| 41.5M | $26.1M | 4.5% | — | — | 2 qtrssince 2022-Q3 | Unchanged 0 | |
AGNC INVESTMENT CORP | 1.8M | $18.1M | 3.1% | $6.13 | 0.00% | 1 qtr | New 81 |
| 12M | $10.9M | 1.9% | — | — | — | Increased 51 | |
Plum Acquisition Corp. III | 1M | $10.2M | 1.8% | — | — | 6 qtrssince 2021-Q3 | Unchanged 0 |
TB SA ACQUISITION CORP | 750,000 | $7.9M | 1.4% | — | — | 8 qtrssince 2021-Q1 | Unchanged 0 |
| 8.3M | $7.8M | 1.3% | — | — | 3 qtrssince 2022-Q2 | Unchanged 0 | |
BLACK SPADE ACQUISITION CO | 500,000 | $5M | 0.9% | — | — | 6 qtrssince 2021-Q3 | Unchanged 0 |
BRAEMAR HOTELS & RESORTS INC | 900,000 | $3.7M | 0.6% | $4.80 | -56.88% | 7 qtrssince 2021-Q2 | Decreased 0 |
VECTOR ACQUISITION CORP II | 250,000 | $2.5M | 0.4% | — | — | 8 qtrssince 2021-Q1 | Unchanged 0 |
LEVERE HOLDINGS CORP | 200,000 | $2M | 0.3% | — | — | 8 qtrssince 2021-Q1 | Unchanged 0 |
AVEANNA HEALTHCARE HLDGS INC | 627,777 | $489,666 | 0.1% | $0.78 | 0.00% | 1 qtr | New 36 |
| 34,823 | $414,394 | 0.1% | — | — | — | Decreased 0 | |
| 600,000 | $108,000 | 0.0% | — | — | — | Unchanged 0 | |
| 39,200 | $3,920 | 0.0% | — | — | — | Unchanged 0 |
KING STREET CAPITAL MANAGEMENT, L.P. manages $577.6M across 17 positions as of Q4 2022. Top holdings: VCSH (59.0%), SEA LTD (12.9%), AFFIRM HLDGS INC (11.6%). Fund DNA: Momentum Trader. HoldingsIntel Rating: 1.5/5.0.
Active quarter - 3 new positions, 25 exits, 3 increased. Top move: VCSH (INCREASED, conviction 100). Portfolio: $578M across 17 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
No active accumulation streaks detected for this filer.
Streaks require 2+ consecutive quarters of increased positions in the most recent period.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer